Last reviewed · How we verify

Anesthetics, Local

University of Alberta · FDA-approved active Small molecule Under review

Anesthetics, Local is a Local anesthetic Small molecule drug developed by University of Alberta. It is currently FDA-approved for Local and regional anesthesia for surgical and dental procedures, Pain relief in minor medical procedures and wound management. Also known as: Ropivacaine / bupivacaine mixture to a final concentration of 0.125% bupivacaine and 0.5% ropivacaine, Ultracain D ohne Adrenalin 20 mg/ml, ATC code N01BB08.

Local anesthetics block sodium channels in nerve cell membranes, preventing the generation and propagation of action potentials to produce localized numbness and pain relief.

Lidocaine is a small molecule anesthetic used in various medical procedures, including surgery and pain management, often administered through spray form for ease of application and patient acceptance. It has been studied for its effectiveness in conditions such as lidocaine toxicity, surgery complications, and anal intraepithelial neoplasia in HIV-infected patients, among others.

At a glance

Generic nameAnesthetics, Local
Also known asRopivacaine / bupivacaine mixture to a final concentration of 0.125% bupivacaine and 0.5% ropivacaine, Ultracain D ohne Adrenalin 20 mg/ml, ATC code N01BB08
SponsorUniversity of Alberta
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Local anesthetics reversibly inhibit sodium influx through voltage-gated sodium channels in nerve fibers, which prevents depolarization and transmission of pain signals. This effect is localized to the area of administration, allowing for regional anesthesia without systemic effects. Different local anesthetics vary in potency, onset time, and duration based on their chemical structure and lipophilicity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Anesthetics, Local

What is Anesthetics, Local?

Anesthetics, Local is a Local anesthetic drug developed by University of Alberta, indicated for Local and regional anesthesia for surgical and dental procedures, Pain relief in minor medical procedures and wound management.

How does Anesthetics, Local work?

Local anesthetics block sodium channels in nerve cell membranes, preventing the generation and propagation of action potentials to produce localized numbness and pain relief.

What is Anesthetics, Local used for?

Anesthetics, Local is indicated for Local and regional anesthesia for surgical and dental procedures, Pain relief in minor medical procedures and wound management.

Who makes Anesthetics, Local?

Anesthetics, Local is developed and marketed by University of Alberta (see full University of Alberta pipeline at /company/university-of-alberta).

Is Anesthetics, Local also known as anything else?

Anesthetics, Local is also known as Ropivacaine / bupivacaine mixture to a final concentration of 0.125% bupivacaine and 0.5% ropivacaine, Ultracain D ohne Adrenalin 20 mg/ml, ATC code N01BB08.

What drug class is Anesthetics, Local in?

Anesthetics, Local belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Anesthetics, Local in?

Anesthetics, Local is FDA-approved (marketed).

What are the side effects of Anesthetics, Local?

Common side effects of Anesthetics, Local include Allergic reactions (rare with ester anesthetics), Systemic toxicity from overdose or intravascular injection, Methemoglobinemia (with benzocaine), Transient neurological symptoms.

What does Anesthetics, Local target?

Anesthetics, Local targets Voltage-gated sodium channels and is a Local anesthetic.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing